Year |
Citation |
Score |
2004 |
Eckert RL, Crish JF, Efimova T, Dashti SR, Deucher A, Bone F, Adhikary G, Huang G, Gopalakrishnan R, Balasubramanian S. Regulation of involucrin gene expression. The Journal of Investigative Dermatology. 123: 13-22. PMID 15191537 DOI: 10.1111/J.0022-202X.2004.22723.X |
0.703 |
|
2003 |
Sturniolo MT, Dashti SR, Deucher A, Rorke EA, Broome AM, Chandraratna RA, Keepers T, Eckert RL. A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. The Journal of Biological Chemistry. 278: 48066-73. PMID 12928434 DOI: 10.1074/Jbc.M307215200 |
0.727 |
|
2003 |
Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, Dashti S. p38 Mitogen-activated protein kinases on the body surface--a function for p38 delta. The Journal of Investigative Dermatology. 120: 823-8. PMID 12713588 DOI: 10.1046/J.1523-1747.2003.12120.X |
0.639 |
|
2002 |
Eckert RL, Efimova T, Dashti SR, Balasubramanian S, Deucher A, Crish JF, Sturniolo M, Bone F. Keratinocyte survival, differentiation, and death: many roads lead to mitogen-activated protein kinase. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 7: 36-40. PMID 12518790 DOI: 10.1046/J.1523-1747.2002.19634.X |
0.708 |
|
2001 |
Dashti SR, Efimova T, Eckert RL. MEK6 regulates human involucrin gene expression via a p38alpha - and p38delta -dependent mechanism. The Journal of Biological Chemistry. 276: 27214-20. PMID 11454875 DOI: 10.1074/Jbc.M100465200 |
0.687 |
|
2001 |
Dashti SR, Efimova T, Eckert RL. MEK7-dependent activation of p38 MAP kinase in keratinocytes. The Journal of Biological Chemistry. 276: 8059-63. PMID 11244091 DOI: 10.1074/Jbc.C000862200 |
0.687 |
|
2000 |
Deucher A, Nagpal S, Chandraratna RA, Di Sepio D, Robinson NA, Dashti SR, Eckert RL. The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. International Journal of Oncology. 17: 1195-203. PMID 11078805 DOI: 10.3892/Ijo.17.6.1195 |
0.717 |
|
Show low-probability matches. |